English | Español
Patient Daily | Jan 31, 2026

Multi-touch attribution models help healthcare marketers improve campaign measurement
Patient Daily | Jan 30, 2026

FDA recommends using minimal residual disease as key endpoint for multiple myeloma drug approvals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
Patient Daily | Jan 30, 2026

Ohio State experts warn against routine use of biotin supplements after cancer
Patient Daily | Jan 29, 2026

Biopharma sector sees increased hiring plans despite recent layoffs
Patient Daily | Jan 29, 2026

Baylor College of Medicine appoints Fred Seigel and Gina Luna to board
Patient Daily | Jan 29, 2026

Biotech investors discuss deal trends and strategy shifts on Denatured podcast
Patient Daily | Jan 29, 2026

Northwestern Medicine team develops artificial lung system enabling double-lung transplant after total pneumonectomy

Trending
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

FDA extends review timelines for four priority voucher drugs
+ Pharmaceuticals
Patient Daily | Jan 23, 2026

Gilead highlights HIV advances and oncology ambitions at JPM healthcare conference
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs